StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
InvestmentJun 10, 2026, 09:16 AM

Nuwellis Closes $6.0 Million Public Offering

AI Summary

Nuwellis, Inc. announced the closing of its registered public offering on June 8, 2026, which generated gross proceeds of approximately $6.0 million before deducting offering expenses. The offering involved the issuance of 1,903,338 shares of common stock, pre-funded warrants to purchase 18,096,662 shares, and accompanying Series C and D Warrants. Following the exercise of pre-funded warrants, the company reported 12,750,321 shares of common stock issued and outstanding as of June 9, 2026.

Key Highlights

  • Nuwellis closed its registered public offering, generating approximately $6.0 million in gross proceeds.
  • The offering included 1,903,338 shares of common stock and pre-funded warrants for 18,096,662 shares.
  • Accompanying Series C Warrants for up to 60,000,000 shares and Series D Warrants for up to 20,000,000 shares were also issued.
  • The public offering price was $0.30 per common share/warrant and $0.2999 per pre-funded warrant/warrant.
  • Pre-funded warrants have an exercise price of $0.0001, while Series C and D Warrants have an exercise price of $0.30.
  • As of June 9, 2026, Nuwellis has 12,750,321 shares of common stock issued and outstanding after pre-funded warrant exercise.